SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001689813-21-000094
Filing Date
2021-06-01
Accepted
2021-06-01 06:55:26
Documents
15
Period of Report
2021-05-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhvn-20210527.htm   iXBRL 8-K 32291
2 EX-99.1 a2021junebhvnpreventiveapp.htm EX-99.1 30927
6 GRAPHIC image_0a.jpg GRAPHIC 2008740
7 GRAPHIC image_1a.jpg GRAPHIC 247126
  Complete submission text file 0001689813-21-000094.txt   3315257

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20210527.xsd EX-101.SCH 1932
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20210527_lab.xml EX-101.LAB 23938
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20210527_pre.xml EX-101.PRE 12646
8 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20210527_htm.xml XML 10495
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38080 | Film No.: 21982907
SIC: 2834 Pharmaceutical Preparations